Provided by Tiger Trade Technology Pte. Ltd.

PharmaCyte Biotech, Inc.

0.7080
-0.0722-9.25%
Post-market: 0.6900-0.0180-2.54%19:08 EDT
Volume:240.19K
Turnover:175.36K
Market Cap:7.60M
PE:-0.70
High:0.8190
Open:0.8190
Low:0.6922
Close:0.7802
52wk High:1.51
52wk Low:0.6300
Shares:10.74M
Float Shares:9.96M
Volume Ratio:0.88
T/O Rate:2.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0080
EPS(LYR):3.19
ROE:-8.24%
ROA:-6.75%
PB:0.20
PE(LYR):0.22

Loading ...

May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 25, 2023

Major Issues Report

Form 8-K - Current report
Nov 23, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 28, 2023

Correspondence

Form CORRESP - Correspondence
Sep 18, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 05, 2023

Correspondence

Form CORRESP - Correspondence
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2023

Major Issues Report

Form 8-K - Current report
Jun 17, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 05, 2023

Correspondence

Form CORRESP - Correspondence
May 30, 2023

Correspondence

Form CORRESP - Correspondence
May 19, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals